{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:17:57Z","timestamp":1789676277136,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,8,30]],"date-time":"2014-08-30T00:00:00Z","timestamp":1409356800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s40262-014-0172-z","type":"journal-article","created":{"date-parts":[[2014,8,29]],"date-time":"2014-08-29T08:13:22Z","timestamp":1409300002000},"page":"1019-1031","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Population Pharmacokinetics Analysis of Vigabatrin in Adults and Children with Epilepsy and Children with Infantile Spasms"],"prefix":"10.1007","volume":"53","author":[{"given":"Jace C.","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth G.","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahlaqa","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Wesche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwain","family":"Tolbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,30]]},"reference":[{"key":"172_CR1","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1517\/14656560903451690","volume":"10","author":"JA Tolman","year":"2009","unstructured":"Tolman JA, Faulkner MA. Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval. Expert Opin Pharmacother. 2009;10:3077\u201389.","journal-title":"Expert Opin Pharmacother"},{"key":"172_CR2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1471-4159.1975.tb06966.x","volume":"25","author":"JD Wood","year":"1975","unstructured":"Wood JD, Peesker SJ. The anticonvulsant action of GABA-elevating agents: a re-evaluation. J Neurochem. 1975;25:277\u201382.","journal-title":"J Neurochem"},{"issue":"Suppl 192","key":"172_CR3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0404.2011.01596.x","volume":"124","author":"E Ben-Menachem","year":"2011","unstructured":"Ben-Menachem E. Mechanism of action of vigabatrin: correcting misperceptions. Acta Neurol Scand. 2011;124(Suppl 192):5\u201315.","journal-title":"Acta Neurol Scand"},{"key":"172_CR4","unstructured":"Sabril (vigabatrin) prescribing information. Deerfield: Lundbeck, October 2013."},{"issue":"Suppl 192","key":"172_CR5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-0404.2011.01598.x","volume":"124","author":"E Fraught","year":"2011","unstructured":"Fraught E. Vigabatrin therapy for refractory complex partial seizures: review of clinical trial experience in the United States. Acta Neurol Scand. 2011;124(Suppl 192):29\u201335.","journal-title":"Acta Neurol Scand"},{"issue":"Suppl 192","key":"172_CR6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1600-0404.2011.01597.x","volume":"124","author":"E Ben-Menachem","year":"2011","unstructured":"Ben-Menachem E, Sander JW. Vigabatrin therapy for refractory complex partial seizures: review of major European trials. Acta Neurol Scand. 2011;124(Suppl 192):16\u201328.","journal-title":"Acta Neurol Scand"},{"key":"172_CR7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/j.1552-4604.1993.tb04688.x","volume":"33","author":"JF Hoke","year":"1993","unstructured":"Hoke JF, Yuh L, Antony KK, et al. Pharmacokinetics of vigabatrin following single and multiple oral doses in normal volunteers. J Clin Pharmacol. 1993;33:458\u201362.","journal-title":"J Clin Pharmacol"},{"issue":"Suppl 1","key":"172_CR8","doi-asserted-by":"crossref","first-page":"23S","DOI":"10.1111\/j.1365-2125.1989.tb03457.x","volume":"27","author":"M Frisk-Holmberg","year":"1989","unstructured":"Frisk-Holmberg M, Kerth P, Meyer P. Effect of food on the absorption of vigabatrin. Br J Clin Pharmacol. 1989;27(Suppl 1):23S\u20135S.","journal-title":"Br J Clin Pharmacol"},{"key":"172_CR9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0090-9556(25)07404-5","volume":"21","author":"SL Durham","year":"1993","unstructured":"Durham SL, Hoke JF, Chen TM. Pharmacokinetics and metabolism of vigabatrin following a single oral dose of [14C]vigabatrin in healthy male volunteers. Drug Metab Dispos. 1993;21:480\u20134.","journal-title":"Drug Metab Dispos"},{"key":"172_CR10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1212\/WNL.46.1.54","volume":"46","author":"JA French","year":"1996","unstructured":"French JA, Mosier M, Walker S, et al. A double-blind, placebo-controlled study of vigabatrin three g\/day in patients with uncontrolled complex partial seizures. Neurology. 1996;46:54\u201361.","journal-title":"Neurology"},{"key":"172_CR11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1528-1157.1999.tb01991.x","volume":"40","author":"C Dean","year":"1999","unstructured":"Dean C, Mosier M, Penry K. Dose-response study of vigabatrin as add-on therapy in patients with uncontrolled complex partial seizures. Epilepsia. 1999;40:74\u201382.","journal-title":"Epilepsia"},{"key":"172_CR12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2125.1990.tb03772.x","volume":"30","author":"E Rey","year":"1990","unstructured":"Rey E, Pons G, Richard MO, et al. Pharmacokinetics of the individual enantiomers of vigabatrin (gamma-vinyl GABA) in epileptic children. Br J Clin Pharmacol. 1990;30:253\u20137.","journal-title":"Br J Clin Pharmacol"},{"key":"172_CR13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1023\/A:1011579109640","volume":"28","author":"KG Kowalski","year":"2001","unstructured":"Kowalski KG, Hutmacher MM. Efficient screening of covariates in population models using Wald\u2019s approximation to the likelihood ratio test. J Pharmacokinet Pharmacodyn. 2001;28:253\u201376.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"172_CR14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1011555016423","volume":"28","author":"Y Yano","year":"2001","unstructured":"Yano Y, Beal SL, Sheiner LB. Evaluating pharmacokinetic\/pharmacodynamic models using the posterior predictive check. J Pharmacokin Pharmacodyn. 2001;28:171\u201392.","journal-title":"J Pharmacokin Pharmacodyn"},{"key":"172_CR15","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.yebeh.2011.08.034","volume":"22","author":"JM Pellock","year":"2011","unstructured":"Pellock JM, Faught E, Sergott RC, et al. Registry initiated to characterize vision loss associated with vigabatrin therapy. Epilepsy Behav. 2011;22:710\u20137.","journal-title":"Epilepsy Behav"},{"key":"172_CR16","unstructured":"Sergott RC, Foroozan R, Pellock JM, et al. Four-year results from the Sabril\u00ae registry yield a low rate of discontinuation secondary to reports of visual deficits. Poster presentation of late-breaking Abstract #3.303 at the 67th Annual Meeting of the American Epilepsy Society, 9 Dec 2013."},{"key":"172_CR17","unstructured":"Vital and Health Statistics, 2000 CDC Growth Charts for the United States: Methods and Development, Data from the National Health Examination Surveys, Series 11, #246; 2002. http:\/\/www.cdc.gov\/nchs\/data\/series\/sr_11\/sr11_246.pdf . Accessed 23 Jan 2014."},{"key":"172_CR18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00467-008-0997-5","volume":"24","author":"MM Rhodin","year":"2009","unstructured":"Rhodin MM, Anderson BJ, Peters AM, et al. Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol. 2009;24:67\u201376.","journal-title":"Pediatr Nephrol"},{"key":"172_CR19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00007691-200402000-00006","volume":"26","author":"A Rousseau","year":"2004","unstructured":"Rousseau A, Leger F, Le Meur Y, et al. Population pharmacokinetic modeling of oral cyclosporine using NONMEM: comparison of absorption pharmacokinetic models and design of a Bayesian estimator. Ther Drug Monit. 2004;26:23\u201330.","journal-title":"Ther Drug Monit"},{"key":"172_CR20","doi-asserted-by":"crossref","first-page":"19S","DOI":"10.1111\/j.1365-2125.1989.tb03456.x","volume":"27","author":"PJ Schechter","year":"1989","unstructured":"Schechter PJ. Clinical pharmacology of vigabatrin. Br J Clin Pharmacol. 1989;27:19S\u201322S.","journal-title":"Br J Clin Pharmacol"},{"key":"172_CR21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1464-410X.2003.04053.x","volume":"91","author":"EF Wahl","year":"2003","unstructured":"Wahl EF, Lahdes-Vasama TT, Churchill BM. Estimation of glomerular filtration rate and bladder capacity: the effect of maturation, ageing, gender and size. BJU Int. 2003;91:255\u201362.","journal-title":"BJU Int"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-014-0172-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40262-014-0172-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-014-0172-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T11:35:23Z","timestamp":1746358523000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40262-014-0172-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,30]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["172"],"URL":"https:\/\/doi.org\/10.1007\/s40262-014-0172-z","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,30]]}}}